101 related articles for article (PubMed ID: 17091453)
1. [Expression of selected genes involved in transport of ions in papillary thyroid carcinoma].
Gałeza-Kulik M; Zebracka J; Szpak-Ulczok S; Czarniecka AK; Kukulska A; Gubała E; Stojcev Z; Wiench M
Endokrynol Pol; 2006; 57 Suppl A():26-31. PubMed ID: 17091453
[TBL] [Abstract][Full Text] [Related]
2. [Expression of DPP4 gene in papillary thyroid carcinoma].
Ozóg J; Jarzab M; Pawlaczek A; Oczko-Wojciechowska M; Włoch J; Roskosz J; Gubała E
Endokrynol Pol; 2006; 57 Suppl A():12-7. PubMed ID: 17091451
[TBL] [Abstract][Full Text] [Related]
3. [Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer].
Hucz J; Kowalska M; Jarzab M; Wiench M
Endokrynol Pol; 2006; 57 Suppl A():18-25. PubMed ID: 17091452
[TBL] [Abstract][Full Text] [Related]
4. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract][Full Text] [Related]
5. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
6. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
7. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma.
Sun J; Zhang J; Lu J; Gao J; Lu T; Ren X; Duan H; Liang Z
Int J Clin Exp Pathol; 2015; 8(11):15072-8. PubMed ID: 26823846
[TBL] [Abstract][Full Text] [Related]
10. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
[TBL] [Abstract][Full Text] [Related]
12. Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?
Hurtado-López LM; Fernández-Ramírez F; Martínez-Peñafiel E; Carrillo Ruiz JD; Herrera González NE
Med Sci Monit; 2015 Jun; 21():1745-51. PubMed ID: 26079849
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
[TBL] [Abstract][Full Text] [Related]
14. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors.
Shyian M; Gryshkova V; Kostianets O; Gorshkov V; Gogolev Y; Goncharuk I; Nespryadko S; Vorobjova L; Filonenko V; Kiyamova R
Exp Oncol; 2011 Jun; 33(2):94-8. PubMed ID: 21716206
[TBL] [Abstract][Full Text] [Related]
16. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.
Li QL; Chen FJ; Lai R; Guo ZM; Luo R; Yang AK
Med Oncol; 2012 Sep; 29(3):1409-17. PubMed ID: 21739307
[TBL] [Abstract][Full Text] [Related]
17. [Percentage of neoplastic cells in papillary thyroid carcinoma: implications for DNA microarray studies of gene expression profile].
Chmielik E; Jarzab M; Lange D
Endokrynol Pol; 2006; 57 Suppl A():32-7. PubMed ID: 17091454
[TBL] [Abstract][Full Text] [Related]
18. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
[TBL] [Abstract][Full Text] [Related]
19. Study of peripheral BRAF(V600E) mutation as a possible novel marker for papillary thyroid carcinomas.
Kwak JY; Jeong JJ; Kang SW; Park S; Choi JR; Park SJ; Kim EK; Chung WY
Head Neck; 2013 Nov; 35(11):1630-3. PubMed ID: 23161556
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in poorly differentiated papillary thyroid carcinomas.
Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]